DSIJ Mindshare

NSE adds Dixon Technologies, 9 other stocks in F&O segment from September series
Karan Dsij
/ Categories: Trending, Mindshare

NSE adds Dixon Technologies, 9 other stocks in F&O segment from September series

National Stock Exchange (NSE) announced the addition of ten stocks to the future & options segment from September series.

The futures and options contracts on ten additional securities are as follows- Can Fin Homes Limited, Dixon Technologies (India) Limited, Hindustan Aeronautics Limited, Indian Energy Exchange Limited, Indiamart Intermesh Limited, Ipca Laboratories Limited, Multi Commodity Exchange of India Limited, Oracle Financial Services Software Limited, Polycab India Limited, and Syngene International Limited.

These future and options of these ten securities would be available for trading with effect from August 27, 2021, the first day of September series, subject to fulfilment of eligibility criteria of Quarter sigma computation cycle of August 2021.

The market lot, scheme of strikes and quantity freeze limit of the above-mentioned securities shall be informed to members on August 26, 2021 through a separate circular.

 

Previous Article Buzzing Stock: Only buyers in Globus Spirits!
Next Article Keep your eyes glued on these eight stocks on Tuesday!
Print
2018 Rate this article:
3.0
Please login or register to post comments.
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR